End-of-day quote
Taiwan S.E.
18:00:00 2024-04-28 EDT
|
5-day change
|
1st Jan Change
|
27.55
TWD
|
+6.17%
|
|
+15.27%
|
+9.76%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,873
|
2,474
|
2,524
|
2,217
|
2,643
|
3,656
|
Enterprise Value (EV)
1 |
1,965
|
2,687
|
2,271
|
2,173
|
2,787
|
3,623
|
P/E ratio
|
11.9
x
|
20.6
x
|
18.5
x
|
51.5
x
|
21.5
x
|
1,255
x
|
Yield
|
9.05%
|
4.33%
|
5.19%
|
4.28%
|
4.46%
|
1.2%
|
Capitalization / Revenue
|
1.67
x
|
1.99
x
|
1.7
x
|
1.75
x
|
1.78
x
|
3.07
x
|
EV / Revenue
|
1.75
x
|
2.16
x
|
1.53
x
|
1.72
x
|
1.88
x
|
3.04
x
|
EV / EBITDA
|
11.7
x
|
18.2
x
|
13.3
x
|
36.4
x
|
16.8
x
|
60.1
x
|
EV / FCF
|
-157
x
|
-162
x
|
13.5
x
|
-17
x
|
-18.6
x
|
-6.87
x
|
FCF Yield
|
-0.64%
|
-0.62%
|
7.43%
|
-5.9%
|
-5.39%
|
-14.5%
|
Price to Book
|
1.47
x
|
2
x
|
1.46
x
|
1.3
x
|
1.49
x
|
1.53
x
|
Nbr of stocks (in thousands)
|
83,091
|
81,504
|
103,214
|
104,630
|
105,716
|
145,669
|
Reference price
2 |
22.55
|
30.35
|
24.45
|
21.19
|
25.00
|
25.10
|
Announcement Date
|
19-03-28
|
20-03-23
|
21-03-31
|
22-03-30
|
23-03-29
|
24-03-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,120
|
1,241
|
1,484
|
1,263
|
1,484
|
1,192
|
EBITDA
1 |
167.4
|
147.8
|
171.2
|
59.72
|
165.9
|
60.32
|
EBIT
1 |
137.1
|
111
|
126.1
|
8.09
|
101.8
|
-12.06
|
Operating Margin
|
12.24%
|
8.94%
|
8.49%
|
0.64%
|
6.86%
|
-1.01%
|
Earnings before Tax (EBT)
1 |
201.6
|
143.4
|
151.7
|
46.14
|
175.6
|
8.026
|
Net income
1 |
161.4
|
125.8
|
129.7
|
43.46
|
143.5
|
2.948
|
Net margin
|
14.4%
|
10.13%
|
8.74%
|
3.44%
|
9.67%
|
0.25%
|
EPS
2 |
1.896
|
1.474
|
1.319
|
0.4113
|
1.162
|
0.0200
|
Free Cash Flow
1 |
-12.53
|
-16.6
|
168.8
|
-128.2
|
-150.1
|
-527
|
FCF margin
|
-1.12%
|
-1.34%
|
11.37%
|
-10.15%
|
-10.12%
|
-44.21%
|
FCF Conversion (EBITDA)
|
-
|
-
|
98.61%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
130.14%
|
-
|
-
|
-
|
Dividend per Share
2 |
2.042
|
1.316
|
1.270
|
0.9073
|
1.116
|
0.3000
|
Announcement Date
|
19-03-28
|
20-03-23
|
21-03-31
|
22-03-30
|
23-03-29
|
24-03-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
91.8
|
213
|
-
|
-
|
144
|
-
|
Net Cash position
1 |
-
|
-
|
252
|
43.6
|
-
|
33.4
|
Leverage (Debt/EBITDA)
|
0.5484
x
|
1.443
x
|
-
|
-
|
0.8677
x
|
-
|
Free Cash Flow
1 |
-12.5
|
-16.6
|
169
|
-128
|
-150
|
-527
|
ROE (net income / shareholders' equity)
|
13%
|
8.78%
|
7.98%
|
1.83%
|
7.7%
|
-0.08%
|
ROA (Net income/ Total Assets)
|
4.59%
|
3.41%
|
3.32%
|
0.19%
|
2.17%
|
-0.25%
|
Assets
1 |
3,517
|
3,687
|
3,910
|
22,996
|
6,622
|
-1,198
|
Book Value Per Share
2 |
15.30
|
15.10
|
16.70
|
16.30
|
16.80
|
16.40
|
Cash Flow per Share
2 |
2.260
|
3.900
|
5.490
|
5.730
|
5.440
|
2.220
|
Capex
1 |
27.5
|
63.4
|
79.8
|
79.1
|
287
|
430
|
Capex / Sales
|
2.46%
|
5.11%
|
5.38%
|
6.26%
|
19.33%
|
36.05%
|
Announcement Date
|
19-03-28
|
20-03-23
|
21-03-31
|
22-03-30
|
23-03-29
|
24-03-19
|
|
1st Jan change
|
Capi.
|
---|
| +9.76% | 123M | | +72.92% | 12.36B | | -19.68% | 7.83B | | +16.20% | 7.21B | | +6.78% | 5.97B | | +7.49% | 5.14B | | +23.97% | 4.43B | | -19.02% | 3.9B | | -41.54% | 2.2B | | +1.24% | 2.02B |
Medical Equipment
|